Spiro[1,3-dioxolane-2,1'(5'H)-indolizine]-7'-acetic acid, α-ethyl-6'-formyl-2',3'-dihydro-5'-oxo-, ethyl ester
CAS1010803-94-7
Spiro[1,3-dioxolane-2,1'(5'H)-indolizine]-7'-acetic acid, α-ethyl-6'-formyl-2',3'-dihydro-5'-oxo-, ethyl ester (CAS 1010803-94-7) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 1010803-94-7
Chemical Specifications
Identifiers
| CAS number | 1010803-94-7 |
|---|---|
| Product name | Spiro[1,3-dioxolane-2,1'(5'H)-indolizine]-7'-acetic acid, α-ethyl-6'-formyl-2',3'-dihydro-5'-oxo-, ethyl ester |
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of Spiro[1,3-dioxolane-2,1'(5'H)-indolizine]-7'-acetic acid, α-ethyl-6'-formyl-2',3'-dihydro-5'-oxo-, ethyl ester?
The CAS Registry Number of Spiro[1,3-dioxolane-2,1'(5'H)-indolizine]-7'-acetic acid, α-ethyl-6'-formyl-2',3'-dihydro-5'-oxo-, ethyl ester is 1010803-94-7.
How can I request a quotation for Spiro[1,3-dioxolane-2,1'(5'H)-indolizine]-7'-acetic acid, α-ethyl-6'-formyl-2',3'-dihydro-5'-oxo-, ethyl ester?
Send an inquiry for Spiro[1,3-dioxolane-2,1'(5'H)-indolizine]-7'-acetic acid, α-ethyl-6'-formyl-2',3'-dihydro-5'-oxo-, ethyl ester (CAS 1010803-94-7) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for Spiro[1,3-dioxolane-2,1'(5'H)-indolizine]-7'-acetic acid, α-ethyl-6'-formyl-2',3'-dihydro-5'-oxo-, ethyl ester
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.